Impact of Craniocaudal Tumor Dimension and the Ninth Edition of the TNM Stage Classification on Prognosis in Resected Thymoma
Open Access
- 18 December 2025
- journal article
- Published by Wiley in Thoracic Cancer
- Vol. 16 (24) , e70204
Abstract
Background: Thymoma is a rare thymic epithelial tumor, and its prognostic factors remain not fully elucidated. This study aimed to identify simple, practical preoperative predictors of prognosis, focusing on tumor dimensions assessed by computed tomography (CT). Methods: We retrospectively analyzed 181 patients who underwent complete or partial resection for thymoma between 2004 and 2022. Tumor size was assessed by measuring the maximum transverse and craniocaudal dimensions on preoperative CT. Freedom from recurrence (FFR) and overall survival (OS) were estimated using the Kaplan–Meier method. Cox proportional hazards models were constructed: Model A included only preoperative variables, while Model B additionally incorporated postoperative factors (e.g., TNM stage classification and histology). Results: During a median follow‐up of 96 months, the 5‐ and 10‐year FFR rates were 78.4% and 71.4%, and the corresponding OS rates were 96.5% and 87.3%, respectively. In multivariate analysis, TNM stage classification and preoperative steroid pulse therapy were significantly associated with FFR, whereas no variables were significantly associated with OS. Model A demonstrated good discriminatory ability ( C ‐index = 0.839), which improved only modestly after including postoperative factors in Model B ( C ‐index = 0.867). In the steroid‐excluded cohort ( N = 148), the craniocaudal tumor dimension emerged as a significant predictor of FFR ( p = 0.027). Conclusions: The craniocaudal tumor dimension measured on preoperative CT was consistently associated with recurrence and may reflect prognostic information embedded within the pathological TNM classification. This easily measurable parameter could complement TNM‐based evaluation in preoperative risk assessment and surgical decision‐making for thymoma.Keywords
Funding Information
- Nagoya City University (2413054)
This publication has 27 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Standard Outcome Measures for Thymic MalignanciesJournal of Thoracic Oncology, 2010
- Imaging ThymomaJournal of Thoracic Oncology, 2010
- Thirty-Five–Year Follow-Up Analysis of Clinical and Pathologic Outcomes of Thymoma SurgeryThe Annals of Thoracic Surgery, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and sizeThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Tumor Recurrence and Survival in Patients Treated for Thymomas and Thymic Squamous Cell Carcinomas: A Retrospective AnalysisJournal of Clinical Oncology, 2004
- Thymoma: A multivariate analysis of factors predicting survivalThe Annals of Thoracic Surgery, 1995
- A review of 79 thymomas: Modification of staging system and reappraisal of conventional division into invasive and non‐invasive thymomaPathology International, 1994
- Follow-up study of thymomas with special reference to their clinical stagesCancer, 1981